Expensive new drugs and the costs of avoiding a small risk.
D001581:Benzothiadiazines; D003362:Cost-Benefit Analysis; D004232:Diuretics; D006016:Glycolates / Q000627:therapeutic use*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D012306:Risk; D049993:Sodium Chloride Symporter Inhibitors / Q000009:adverse effects*; D013989:Ticrynafen / Q000627:therapeutic use*; D014527:Uric Acid / Q000097:blood
D001581:Benzothiadiazines; D004232:Diuretics; D006016:Glycolates; D049993:Sodium Chloride Symporter Inhibitors; D014527:Uric Acid; D013989:Ticrynafen